Insuvia

📣 Next week, 6 - 7 November, meet Insuvia Chief Operating Officer, Martynas Juzenas & Head of Pharmacovigilance, Ada Stelmakiene, at DIA Global Forum for QPPV. Our team is excited to join this event, bringing together pharmaceutical industry professionals dedicated to advancing drug safety. It’s a valuable opportunity for discussions around industry challenges, best practices, and innovative solutions in pharmacovigilance. Let's connect: https://lnkd.in/dswgnGn See you in Amsterdam! #Insuvia #DIAForum #Pharmacovigilance #QPPV #DrugSafety

Day 1 at World Drug Safety Congress Americas! If you're attending the event, make sure to stop by booth #627 and connect with our dedicated #Insuvia team: Justina Simanaviciute & Jonas Leonavicius. We are ready to share insights into how Insuvia supports pharmaceutical and biotech companies worldwide. #WDSUS #WordlDrugSafetyCongressAmericas

PV System Transfer is a complex yet increasingly relevant process in today’s regulatory and business environment. In an industry as dynamic and heavily regulated as pharmaceuticals, timely and well-planned PV system transfers are instrumental in enabling companies to meet global standards, manage safety effectively, and remain competitive. Join Insuvia webinar as Ada Stelmakiene seeks to share her knowledge on key considerations for any PV system change. Date: 28 November 2024 Time: 12:00 EET Presenter: Ada Stelmakienė, Head of Pharmacovigilance Secure your spot today and don’t miss the opportunity to delve into one of the standout topics from this year’s World Drug Safety Congress Europe! 👉 Register here: https://lnkd.in/dyXkjehn

🎾 Teamwork on and off the court! At #Insuvia, we believe that strong team relationships are the foundation of success, both in and out of the workplace. Recently, we took our collaboration to the next level while learning and playing #padel! For many of us, it was the first time, but the support, laughter, and team spirit made every challenge an opportunity to grow together. From navigating tricky shots to celebrating each win, it was a fantastic way to bond as a team and sharpen our collaboration skills in a fun and active environment. Here's to more moments that strengthen our teamwork and keep us connected! 💪 #TeamBuilding #PadelHub #InsuviaTeam #StrongerTogether

🌍 Requirements for Nomination of a PV Contact Person Navigating global #pharmacovigilance regulations is crucial for #pharmaceutical companies to ensure patient safety and regulatory compliance. #Insuvia article offers a detailed summary of the requirements for nominating a pharmacovigilance contact person across different countries. Do not miss this must-read if you're looking for a clear, country-specific overview of local PV person and nomination requirements. 👉 Explore the article here: https://lnkd.in/dXS6Hgdw

🔔 We’re excited to announce that Insuvia will be attending the World Drug Safety Congress Americas in Boston, MA, on October 29-30, 2024! Meet Jonas Leonavicius, and Justina Simanaviciute at booth #627 to discuss how #Insuvia can support your #pharmacovigilance and #regulatory needs. 📆 Schedule a meeting with our team at: sales@insuvia.com 📍 See you at Boston Convention and Exhibition Center!

👓 Read #Insuvia latest blog post by Dina Velce, Senior Regulatory Affairs Specialist, where she covers key reasons for variation application invalidations and how to avoid them. ☑ Looking for practical tips? There's a helpful checklist available too! Read the full post and get the checklist here: 👉 https://lnkd.in/dSvr4m7K

Last week, team #Insuvia had an opportunity to participate in World Drug Safety Congress Europe 2024. 🌟 During the event Insuvia's Head of Pharmacovigilance, Ada Stelmakiene, presented ideas on ensuring seamless PV System Transfer. The conference itself was packed with insightful meetings, idea sharing, and discussions that will shape the future of #pharmacovigilance in the coming years. Here is a wrap up of the hottest topics:   ♨ #ArtificialIntelligence (#AI) is stepping more and more confident steps in pharmacovigilance. Most of discussions were not only about possibilities to use AI but also Generative AI in a daily work. AI is transforming pharmacovigilance by improving adverse event detection, risk prediction, and automating data analysis, making drug safety processes faster and more accurate.   ♨ #InspectionExperience is always a hot topic and this year were couple of discussions regarding the subject. Presenters shared very different experiences from the inspections in Australia, Taiwan, Turkey, Spain and other. Panel discussion of Regulators shared insights on how PV legislation could be harmonized globally.   ♨ There are massive discussions on #Outsourcing solutions, models, and the best practices both from service providers and MAHs. This shows that outsourcing is an essential part of pharmacovigilance systems, and the smooth partnerships helps to ensure operational excellence.   ♨ Couple of presentations highlighted what is waiting all the pharmacovigilance community in the future. It was highlighted that the legislative landscape is still changing, and it seems that there is a trend of increasing a new/updated legislative documents in the future. Pharmacovigilance systems evolving both due to companies’ initiatives and legislative requirements and it goes in parallel. 👇 Check out our team's time in Amsterdam: Lauryna Gaižutienė, Martynas Juzenas, Justina Simanaviciute, Ada Stelmakiene, Jonas Leonavicius, Donatas Grina #WorldDrugSafetyCongress #WDS #Terrapin

This week, the #Insuvia team, represented by Justina Simanaviciute and Lina Kausakiene, had the pleasure of attending the CPHI event in Milan! We’re excited to share a few moments from an event filled with insightful discussions and meaningful meetings. If we missed the chance to connect during CPHI Milan, we’d love to hear from you! 🔆 Reach out to us here: https://lnkd.in/dswgnGn #CPHI #RegulatoryAffairs #Pharma #DrugDevelopment #Pharmaceuticals

First day of World Drug Safety Congress Europe 2024! 🔔 Don’t miss our Head of Pharmacovigilance, Ada Stelmakiene, as she discusses "Pharmacovigilance System Transfer: Ensuring a Seamless Shift." 🕧Today at 12:45 📍 PV Outourcing, G109 What is more, stop by #Insuvia stand and meet the rest of the team: Lauryna Gaižutienė, Donatas Grina, Martynas Juzenas, Jonas Leonavicius, Justina Simanaviciute. Let us explore how we can collaborate on innovative #pharmacovigilance solutions! #WDSC2024 #drugsafety